Corbus Pharmaceuticals
CRBP
CRBP
28 hedge funds and large institutions have $5.8M invested in Corbus Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Holders
28
Holding in Top 10
–
Calls
$280K
Puts
$5K
Top Buyers
| 1 | +$140K | |
| 2 | +$76.9K | |
| 3 | +$20K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$12K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8 |
Top Sellers
| 1 | -$73K | |
| 2 | -$35.6K | |
| 3 | -$3.04K | |
| 4 |
Morgan Stanley
New York
|
-$2.56K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$2K |